214 related articles for article (PubMed ID: 30209539)
21. Protein kinase cepsilon has the potential to advance the recurrence of human prostate cancer.
Wu D; Foreman TL; Gregory CW; McJilton MA; Wescott GG; Ford OH; Alvey RF; Mohler JL; Terrian DM
Cancer Res; 2002 Apr; 62(8):2423-9. PubMed ID: 11956106
[TBL] [Abstract][Full Text] [Related]
22. TGF-β promotes glioma cell growth via activating Nodal expression through Smad and ERK1/2 pathways.
Sun J; Liu SZ; Lin Y; Cao XP; Liu JM
Biochem Biophys Res Commun; 2014 Jan; 443(3):1066-72. PubMed ID: 24370825
[TBL] [Abstract][Full Text] [Related]
23. Loss of phosphatase and tensin homologue increases transforming growth factor beta-mediated invasion with enhanced SMAD3 transcriptional activity.
Hjelmeland AB; Hjelmeland MD; Shi Q; Hart JL; Bigner DD; Wang XF; Kontos CD; Rich JN
Cancer Res; 2005 Dec; 65(24):11276-81. PubMed ID: 16357132
[TBL] [Abstract][Full Text] [Related]
24. Regulation of prostate cancer cell survival by protein kinase Cepsilon involves bad phosphorylation and modulation of the TNFalpha/JNK pathway.
Meshki J; Caino MC; von Burstin VA; Griner E; Kazanietz MG
J Biol Chem; 2010 Aug; 285(34):26033-40. PubMed ID: 20566643
[TBL] [Abstract][Full Text] [Related]
25. Cytoplasmic PML promotes TGF-β-associated epithelial-mesenchymal transition and invasion in prostate cancer.
Buczek ME; Miles AK; Green W; Johnson C; Boocock DJ; Pockley AG; Rees RC; Hulman G; van Schalkwyk G; Parkinson R; Hulman J; Powe DG; Regad T
Oncogene; 2016 Jun; 35(26):3465-75. PubMed ID: 26549027
[TBL] [Abstract][Full Text] [Related]
26. Constitutive Smad linker phosphorylation in melanoma: a mechanism of resistance to transforming growth factor-β-mediated growth inhibition.
Cohen-Solal KA; Merrigan KT; Chan JL; Goydos JS; Chen W; Foran DJ; Liu F; Lasfar A; Reiss M
Pigment Cell Melanoma Res; 2011 Jun; 24(3):512-24. PubMed ID: 21477078
[TBL] [Abstract][Full Text] [Related]
27. Thymoquinone inhibits epithelial-mesenchymal transition in prostate cancer cells by negatively regulating the TGF-β/Smad2/3 signaling pathway.
Kou B; Liu W; Zhao W; Duan P; Yang Y; Yi Q; Guo F; Li J; Zhou J; Kou Q
Oncol Rep; 2017 Dec; 38(6):3592-3598. PubMed ID: 29039572
[TBL] [Abstract][Full Text] [Related]
28. MicroRNA-323-3p inhibits cell invasion and metastasis in pancreatic ductal adenocarcinoma via direct suppression of SMAD2 and SMAD3.
Wang C; Liu P; Wu H; Cui P; Li Y; Liu Y; Liu Z; Gou S
Oncotarget; 2016 Mar; 7(12):14912-24. PubMed ID: 26908446
[TBL] [Abstract][Full Text] [Related]
29. NPAS2 promotes aerobic glycolysis and tumor growth in prostate cancer through HIF-1A signaling.
Ma S; Chen Y; Quan P; Zhang J; Han S; Wang G; Qi R; Zhang X; Wang F; Yuan J; Yang X; Jia W; Qin W
BMC Cancer; 2023 Mar; 23(1):280. PubMed ID: 36978001
[TBL] [Abstract][Full Text] [Related]
30. Transcription factor specificity protein 1-mediated Serine/threonine kinase 39 upregulation promotes the proliferation, migration, invasion and epithelial-mesenchymal transition of hepatocellular carcinoma cells by activating the transforming growth factor-β1 /Smad2/3 pathway.
Wang J; Fan Z; Li J; Yang J; Liu X; Cheng J
Bioengineered; 2021 Dec; 12(1):3566-3577. PubMed ID: 34281492
[TBL] [Abstract][Full Text] [Related]
31. Rb/E2F4 and Smad2/3 link survivin to TGF-beta-induced apoptosis and tumor progression.
Yang J; Song K; Krebs TL; Jackson MW; Danielpour D
Oncogene; 2008 Sep; 27(40):5326-38. PubMed ID: 18504435
[TBL] [Abstract][Full Text] [Related]
32. Smad2 and Smad3 have opposing roles in breast cancer bone metastasis by differentially affecting tumor angiogenesis.
Petersen M; Pardali E; van der Horst G; Cheung H; van den Hoogen C; van der Pluijm G; Ten Dijke P
Oncogene; 2010 Mar; 29(9):1351-61. PubMed ID: 20010874
[TBL] [Abstract][Full Text] [Related]
33. Pin1 promotes transforming growth factor-beta-induced migration and invasion.
Matsuura I; Chiang KN; Lai CY; He D; Wang G; Ramkumar R; Uchida T; Ryo A; Lu K; Liu F
J Biol Chem; 2010 Jan; 285(3):1754-64. PubMed ID: 19920136
[TBL] [Abstract][Full Text] [Related]
34. PKCε Is an Essential Mediator of Prostate Cancer Bone Metastasis.
Gutierrez-Uzquiza A; Lopez-Haber C; Jernigan DL; Fatatis A; Kazanietz MG
Mol Cancer Res; 2015 Sep; 13(9):1336-46. PubMed ID: 26023164
[TBL] [Abstract][Full Text] [Related]
35. Berberine Suppresses EMT in Liver and Gastric Carcinoma Cells through Combination with TGF
Du H; Gu J; Peng Q; Wang X; Liu L; Shu X; He Q; Tan Y
Oxid Med Cell Longev; 2021; 2021():2337818. PubMed ID: 34712379
[TBL] [Abstract][Full Text] [Related]
36. Opposite functions of HIF-α isoforms in VEGF induction by TGF-β1 under non-hypoxic conditions.
Chae KS; Kang MJ; Lee JH; Ryu BK; Lee MG; Her NG; Ha TK; Han J; Kim YK; Chi SG
Oncogene; 2011 Mar; 30(10):1213-28. PubMed ID: 21057546
[TBL] [Abstract][Full Text] [Related]
37. Histone 3 lysine 9 (H3K9) methyltransferase recruitment to the interleukin-2 (IL-2) promoter is a mechanism of suppression of IL-2 transcription by the transforming growth factor-β-Smad pathway.
Wakabayashi Y; Tamiya T; Takada I; Fukaya T; Sugiyama Y; Inoue N; Kimura A; Morita R; Kashiwagi I; Takimoto T; Nomura M; Yoshimura A
J Biol Chem; 2011 Oct; 286(41):35456-35465. PubMed ID: 21862595
[TBL] [Abstract][Full Text] [Related]
38. Genetic ablation of PKC epsilon inhibits prostate cancer development and metastasis in transgenic mouse model of prostate adenocarcinoma.
Hafeez BB; Zhong W; Weichert J; Dreckschmidt NE; Jamal MS; Verma AK
Cancer Res; 2011 Mar; 71(6):2318-27. PubMed ID: 21406403
[TBL] [Abstract][Full Text] [Related]
39. Small C-terminal domain phosphatases dephosphorylate the regulatory linker regions of Smad2 and Smad3 to enhance transforming growth factor-beta signaling.
Wrighton KH; Willis D; Long J; Liu F; Lin X; Feng XH
J Biol Chem; 2006 Dec; 281(50):38365-75. PubMed ID: 17035229
[TBL] [Abstract][Full Text] [Related]
40. Ras inhibits TGF-β-induced KLF5 acetylation and transcriptional complex assembly via regulating SMAD2/3 phosphorylation in epithelial cells.
Guo P; Xing C; Fu X; He D; Dong JT
J Cell Biochem; 2020 Mar; 121(3):2197-2208. PubMed ID: 31724223
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
